Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BioDelivery raises $10.5 million in IPO

Drug delivery company BioDelivery Sciences (BDSI) raised $10.5 million

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE